AbbVie
ABBV
#25
Rank
$397.62 B
Marketcap
$224.98
Share price
-0.08%
Change (1 day)
31.60%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2025 (TTM): $1.66 Billion USD

According to AbbVie's latest financial reports the company's current earnings are $59.64 Billion USD. In 2024 the company made an earning of $3.71 Billion USD a decrease over its 2023 earnings that were of $6.25 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) $1.66 B-55.33%
2024 $3.71 B-40.54%
2023 $6.25 B-53.62%
2022 $13.47 B3.76%
2021 $12.98 B282.25%
2020 $3.39 B-59.67%
2019 $8.42 B62.13%
2018 $5.19 B-32.74%
2017 $7.72 B-1.99%
2016 $7.88 B18.65%
2015 $6.64 B180.5%
2014 $2.36 B-55.57%
2013 $5.33 B-6.86%
2012 $5.72 B56.05%
2011 $3.66 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
$11.85 B 613.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$8.03 B 383.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$22.50 B 1,255.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$8.24 B 396.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
$9.88 B 495.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
$1.90 B 14.70%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
$9.32 B 461.62%๐Ÿ‡ฌ๐Ÿ‡ง UK
AstraZeneca
AZN
$13.09 B 688.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
$0.58 B-64.87%๐Ÿ‡บ๐Ÿ‡ธ USA